Older adults demonstrate biomarker evidence of the persistent inflammation, immunosuppression and catabolism syndrome (PICS) after sepsis.
暂无分享,去创建一个
B. Brumback | S. Anton | L. Moldawer | P. Efron | S. Brakenridge | A. Bihorac | F. Moore | R. Mankowski | Dijoia B. Darden | G. Ghita
[1] A. Salminen. Increased immunosuppression impairs tissue homeostasis with aging and age-related diseases , 2020, Journal of molecular medicine.
[2] H. Crossland,et al. Glucagon‐like peptide 1 infusions overcome anabolic resistance to feeding in older human muscle , 2020, Aging cell.
[3] B. Brumback,et al. Phenotypic heterogeneity by site of infection in surgical sepsis: a prospective longitudinal study , 2020, Critical Care.
[4] B. Brumback,et al. Older Sepsis Survivors Suffer Persistent Disability Burden and Poor Long-Term Survival , 2020, Journal of the American Geriatrics Society.
[5] F. Moore,et al. Chronic Critical Illness Patients Fail to Respond to Current Evidence-Based Intensive Care Nutrition Secondarily to Persistent Inflammation, Immunosuppression, and Catabolic Syndrome. , 2020, JPEN. Journal of parenteral and enteral nutrition.
[6] Nikolas I. Krieger,et al. Association of Lymphopenia With Risk of Mortality Among Adults in the US General Population , 2019, JAMA network open.
[7] Marie-Pierre L. Gauthier,et al. Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis , 2019, Critical Care.
[8] R. Hotchkiss,et al. IL-10 Has Differential Effects on the Innate and Adaptive Immune Systems of Septic Patients , 2019, The Journal of Immunology.
[9] S. Anton,et al. Current Epidemiology of Surgical Sepsis: Discordance Between Inpatient Mortality and 1-Year Outcomes. , 2019, Annals of surgery.
[10] Octavia M Peck Palmer,et al. Long-term Host Immune Response Trajectories Among Hospitalized Patients With Sepsis , 2019, JAMA network open.
[11] L. Moldawer,et al. Persistently Elevated Glucagon-Like Peptide-1 Levels among Critically Ill Surgical Patients after Sepsis and Development of Chronic Critical Illness and Dismal Long-Term Outcomes. , 2019, Journal of the American College of Surgeons.
[12] M. Rapoport,et al. Sepsis‐induced activation of endogenous GLP‐1 system is enhanced in type 2 diabetes , 2018, Diabetes/metabolism research and reviews.
[13] H. Ueno,et al. Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy , 2018, Front. Immunol..
[14] Derek C. Angus,et al. Enhancing Recovery From Sepsis: A Review , 2018, JAMA.
[15] B. Brumback,et al. Evidence for Persistent Immune Suppression in Patients Who Develop Chronic Critical Illness After Sepsis , 2017, Shock.
[16] B. Brumback,et al. Sepsis and Critical Illness Research Center investigators: protocols and standard operating procedures for a prospective cohort study of sepsis in critically ill surgical patients , 2017, BMJ Open.
[17] David T. Huang,et al. Endothelial Permeability and Hemostasis in Septic Shock: Results From the ProCESS Trial , 2017, Chest.
[18] F. Tacke,et al. GLP-1 Levels Predict Mortality in Patients with Critical Illness as Well as End-Stage Renal Disease. , 2017, The American journal of medicine.
[19] G. Bernard,et al. Frailty and Subsequent Disability and Mortality among Patients with Critical Illness , 2017, American journal of respiratory and critical care medicine.
[20] B. Brumback,et al. Human Myeloid-derived Suppressor Cells are Associated With Chronic Immune Suppression After Severe Sepsis/Septic Shock , 2017, Annals of surgery.
[21] H. J. Kolmos,et al. Association between Hypoalbuminaemia and Mortality in Patients with Community-Acquired Bacteraemia Is Primarily Related to Acute Disorders , 2016, PloS one.
[22] R. Hotchkiss,et al. Sepsis and septic shock , 2016, Nature Reviews Disease Primers.
[23] H. Baker,et al. Advanced age is associated with worsened outcomes and a unique genomic response in severely injured patients with hemorrhagic shock , 2015, Critical Care.
[24] Janko Nikolich-Zugich,et al. Global analyses revealed age-related alterations in innate immune responses after stimulation of pathogen recognition receptors , 2015, Aging cell.
[25] R. Hotchkiss,et al. Persistent Lymphopenia After Diagnosis of Sepsis Predicts Mortality , 2014, Shock.
[26] C. Cairns,et al. Age-Related Differences in Biomarkers of Acute Inflammation During Hospitalization for Sepsis , 2014, Shock.
[27] E. Montecino-Rodriguez,et al. Causes, consequences, and reversal of immune system aging. , 2013, The Journal of clinical investigation.
[28] L. Moldawer,et al. Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care , 2012, The journal of trauma and acute care surgery.
[29] M. Hiroe,et al. Time-Dependent Alterations of VEGF and Its Signaling Molecules in Acute Lung Injury in a Rat Model of Sepsis , 2012, Inflammation.
[30] B. McKinley,et al. Computer protocol facilitates evidence-based care of sepsis in the surgical intensive care unit. , 2011, The Journal of trauma.
[31] D. Angus,et al. Toward an integrated research agenda for critical illness in aging. , 2010, American journal of respiratory and critical care medicine.
[32] D. Chinkes,et al. Modulation of the hypermetabolic response to trauma: temperature, nutrition, and drugs. , 2009, Journal of the American College of Surgeons.
[33] A. E. El Solh,et al. Outcome of Septic Shock in Older Adults After Implementation of the Sepsis “Bundle” , 2008, Journal of the American Geriatrics Society.
[34] D. Chung,et al. IGF-1 protects intestinal epithelial cells from oxidative stress-induced apoptosis. , 2006, The Journal of surgical research.
[35] R. Bodnar,et al. IP-10 Blocks Vascular Endothelial Growth Factor-Induced Endothelial Cell Motility and Tube Formation via Inhibition of Calpain , 2006, Circulation research.
[36] Marc Moss,et al. The effect of age on the development and outcome of adult sepsis* , 2006, Critical care medicine.
[37] I. White. Uses and limitations of randomization-based efficacy estimators , 2005, Statistical methods in medical research.
[38] J. Vincent,et al. Hypoalbuminemia in Acute Illness: Is There a Rationale for Intervention?: A Meta-Analysis of Cohort Studies and Controlled Trials , 2003, Annals of surgery.
[39] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[40] S. Grad,et al. Strongly Enhanced Serum Levels of Vascular Endothelial Growth Factor (VEGF) after Poly-trauma and Burn , 1998, Clinical chemistry and laboratory medicine.
[41] C. Mackay,et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.
[42] R. McCARTER,et al. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. , 1985, The Journal of clinical endocrinology and metabolism.